Welcome to CDC stacks | Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Children Aged 6–18 Years with Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP) - 57063 | Morbidity and Mortality Weekly Report (MMWR) | Advisory Committee on Immunization Practices (ACIP)
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Children Aged 6–18 Years with Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
  • Published Date:
    Jun 28 2013
  • Source:
    MMWR Morb Mortal Wkly Rep. 2013; 62(25):521-524.
  • Language:
    English
Filetype[PDF-203.50 KB]


Details:
No Related Documents.
You May Also Like: